Form D · Biotechnology
ORTHOCON INC
North Brunswick, NJ · CIK 0001446928
Offering snapshot reported Apr 10, 2009 · SEC filing
- Reported sold
- $10.5M Offering amount: $25M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 10, 2009 | Initial | $10,499,949 | No comparison | Not reported | SEC filing |
| Sep 29, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-123073
Source: Form D, filed Apr 10, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Klaus Breiner, Ph.D | Director |
| David Knaack | Executive |
| Richard Kronenthal, Ph.D | Executive |
| Alan Levy, Ph.D | Director |
| John Pacifico | Executive |
| Seth Rudnick, M.D. | Director |
| Paul Sohmer, M.D. | Director, Executive |
| Joyce Tsang, Ph.D | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
675 Us Highway One
North Brunswick, NJ, 08902
North Brunswick, NJ, 08902